StaceyGoodmanMD

Hematology • Nashville, TN

Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

Dr. Goodman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goodman's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1993
Vanderbilt University Medical CenterResidency, Internal Medicine, 1987 - 1990
New York University School of MedicineClass of 1987

Certifications & Licensure

TN State Medical License 1993 - 2023
AL State Medical License 2020 - 2020
American Board of Internal Medicine Hematology

Clinical Trials

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
Completed
Phase 3
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
Terminated
Phase 2, Phase 3
Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
Completed
Phase 3
Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) Start of enrollment: 2009 Apr 01
Completed
Phase 2
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Start of enrollment: 2016 Mar 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

252 citations
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard
The New England Journal of Medicine. 2021-06-30
13 citations
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardle...
Robert F. Cornell, Raphael Fraser, Luciano J. Costa, Stacey Goodman, Noel Estrada-Merly
Transplantation and Cellular Therapy. 2021-03-01
Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Tran...
Dilan A Patel, Karina A. Mendoza, Heidi Chen, Brian G. Engelhardt, Bipin N. Savani
Journal of Hematology. 2021-02-06